Chami

2025-26 Labor Government Budget proposals as they relate to Health:  In a rare 4th budget announcement within a single term of government, the Labor Treasurer, Hon Jim Chalmers, appealed for stability and the chance for a second term for Labor to guide Australians through “uncertain times”. The budget has a strong focus on cost-of-living pressures […]

  The peak body representing private pathology in Australia, Australian Pathology, launched a widespread campaign that has been running since 2024 – “Keep Pathology Bulk Billed”. This multi-channel initiative can be seen on TV commercials, Mainstream news and media articles, social media, and billboards. Aimed at raising awareness of the long-term stagnation in Medicare rebates

Kathy, like over 40% of newly diagnosed lung cancer patients, was diagnosed when her cancer was already Stage 4 and terminal. The good news? Genomic testing of Kathy’s cancer identified a specific gene for which there is a targeted treatment. Kathy takes a daily pill that is currently keeping her alive. “If every single lung

Five stakeholders join voices calling for faster and more equitable access to genetic testing in breast cancer For Amber, as a mother with stage 4 breast cancer, her concern is for her family. Amber wants those she loves to be able to access genetic testing. Her hope is with this knowledge, perhaps they avoid the

We want cancer patients to focus on their own personal health journey, not worry about whether they have access to all the tools and information for the best possible outcome. New technologies for endometrial cancers that identify DNA mutations that inform targeted therapy are recognised internationally as the standard of care yet are not universally

The HTA Review found there is urgent need for system reform, with patients experiencing profound negative consequences caused by delays in access to new treatments. This review was initiated as part of the last Medicines Agreement and as such was largely limited to Health Technology Assessment and the Pharmaceutical Benefits Schedule (PBS). While Pathology Technology

Pathology Technology Australia and InGeNA Limited welcome the  move to legislate a total ban on the use of genomic data by Life Insurers to discriminate against individuals. “If Australia is to maintain equitable, timely, and economically sustainable healthcare for all Australians we will need to pivot towards more predictive, preventative, and personalised methods of healthcare

After a week in hospital with dangerously high blood pressure, Sarah’s body finally went into seizure and she was rushed into an emergency C-section, with her baby not yet full term.   “If I had access to a test that could predict my risk for pre-eclampsia I could have prevented a life threatening situation for

The Missing Piece – Lung Cancer Molecular Pathology Chest pain. Shortness of breath. Persistent cough. Fatigue. Is it “a bit of a cold” or signs of something much more serious? Lung cancer is Australia’s biggest cancer killer. Anyone can get lung cancer, even if you have never smoked. If found early, outcomes are improved, but

We are experiencing a diabetes epidemic. An estimated 1.5 million Australians (1 in 20) are living with a diagnosis of diabetes, but this condition does not impact all Australian communities equally and not all diabetes patients have equal access to life-changing technology. Watch Ray and Renza share their stories and the critical role technology plays